Ghost Management Research Group

Breaking news: My co-authored paper with @MA_Gagnon has skyrocketed into the top 10% of most-viewed papers in the journal for 2023! 🎉 Thanks to everyone who read it, cited it, or accidentally opened. Hard work wins. Caffeine survives. Sleep? Still pending.

My latest paper with @Bluemediagrad : a scoping review revealing the secrets of the #chemicalindustry. To increase earning capacity, pervasive conflicts of interests and the systematic production of ignorance are central strategies for this sector. dx.plos.org/10.1371/journa…

@MA_Gagnon & I just dropped our new open access scoping review, and it’s about how researchers have been digging into internal corporate documents to find out what chemical companies don’t want us to know. 📑: journals.plos.org/plosone/arti... 📑: doi.org/10.1002/cesm.1… #newpaper

🥳SPPA's Professor Marc-André has significantly contributed to two new books published by Garnier-Gallimard.📚 librairie-gallimard.com/livre/97824061… librairie-gallimard.com/livre/97824061… These translations bring seminal works of American Institutional Economics to a wider French-speaking audience!👏

@MA_Gagnon @RobinShaban Congratulations, Dr. Shaban!!!🎉🎉🎉

So proud of my new ex-PhD student, Dr @RobinShaban Not only they successfully defended their PhD dissertation "A Critical Examination of Efficiency within Competition Law", but they also obtained a Senate Medal for Outstanding Academic Achievement in the process... Bravo Robin!

How an opioid giant deployed a playbook for moulding doctors’ minds bmj.com/content/385/bm…

Pratiques anticoncurrentielles et concentration outrageuse dans la distribution des médicaments de spécialité : l’AQPP dépose une action collective contre certains de ses membres monpharmacien.ca/nouvelles/prat…

Will definitely tune in. @haronba @Drug_Evidence @DrNancyOlivieri @cmrherder @MA_Gagnon @furlinil @DonDavies

A recent presentation on Bill C-64 for Universal Pharmacare in Canada (For contraceptives and diabetes products). Prescription for Progress? Exploring Canada's New Pharmacare Program youtu.be/o6_lmf4tEfU?si… via @YouTube

Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health frontiersin.org/articles/10.33… @FrontiersIn Medicine @MA_Gagnon @MGarciaCarrillo @CONICETDialoga @Exactas_UBA

Our Special Issue: "Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health" Now fully available in Frontiers in Medicine: frontiersin.org/research-topic… #MedicalResearch

Just dropped our paper like it's hot!💥 Our deep dive into ClinicalTrials.gov spills the tea on these trials, with a Canadian twist, comparing industry-funded vs. non-industry-funded trials. We did some manual scavenger hunt in the medical lit ✨ 📄ijhpm.com/article_4576.h…

Join @MA_Gagnon, @FafardPatrick, Christabelle Sethna and @vanessagruben for a lunchtime sem/webinar looking at Canada's new national pharmacare plan. Monday March 4 11:30 am. Hosted by @ottawahealthlaw @uocommonlaw @uOttawa. All welcome! ottawahealthlaw.ca/events/pharmac…

Joignez-vous à @MA_Gagnon, @FafardPatrick, Christabelle Sethna et @vanessagruben pour un séminaire/webinaire « Exploring Canada's New Pharmacare Program » le lundi 4 mars à 11 h 30. Organisé par @ottawahealthlaw @uocommonlaw @uOttawa. ottawahealthlaw.ca/events/pharmac…

With only 3,280 words above what I committed, I have a new book manuscript!! Now, it is time to polish 💅 and re-read again and again and again. @VersoBooks

22% des Canadiens ont coupé leurs comprimés, sauté des doses ou n’ont pas renouvelé une ordonnance pour économiser. ledevoir.com/societe/807195…

Access to Rx drugs in Canada. Poll finds nearly 1 in 4 Canadian report skipping doses, splitting pills, or not filling prescriptions due to cost - 2 largest health charity patient organizations call on federal government to table pharmacare now cancer.ca/en/about-us/me…

White House Takes Additional Steps Towards Fairer Pricing for Drugs Developed With Taxpayer Funding citizen.org/news/white-hou…

Ma réponse à ceux qui cherchent à organiser la couverture publique des médicaments selon les intérêts des compagnies d’assurance plutôt que selon l’intérêt de la population. lapresse.ca/dialogue/opini… #pharmacare #insurance @GMresearchgroup @CFNU @FPACarleton @CarletonSPPA